Published in Mol Genet Metab on October 26, 2011
Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study. Genet Med (2015) 1.03
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93
Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome. Transl Psychiatry (2016) 0.76
Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits. Hum Genome Var (2016) 0.75
Previously Unidentified Single Nucleotide Polymorphisms in HIV/AIDS Cases Associate with Clinical Parameters and Disease Progression. Biomed Res Int (2016) 0.75
N1303K (c.3909C>G) mutation and splicing: implication of its c.[744-33GATT(6); 869+11C>T] complex allele in CFTR exon 7 aberrant splicing. Biomed Res Int (2015) 0.75
Newborn Screening Quality Assurance Program for CFTR Mutation Detection and Gene Sequencing to Identify Cystic Fibrosis. J Inborn Errors Metab Screen (2016) 0.75
The International HapMap Project. Nature (2003) 73.65
Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat (2002) 5.43
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
Dried-blood spot screening for cystic fibrosis in the newborn. Lancet (1979) 4.30
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med (2001) 3.72
Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med (2004) 3.32
Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet (2000) 2.67
A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet (1993) 2.64
Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med (1991) 2.38
Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep (2004) 2.25
A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med (1994) 2.25
The phenotypic consequences of CFTR mutations. Ann Hum Genet (2003) 2.09
Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat (1997) 1.69
Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet (1999) 1.67
Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest (2008) 1.57
Modifier genes convert "simple" Mendelian disorders to complex traits. Mol Genet Metab (2000) 1.39
Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. Hum Mol Genet (1993) 1.31
Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet (1993) 1.19
Consequences of complexity within biological networks: robustness and health, or vulnerability and disease. Mol Genet Metab (2001) 1.07
Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen (2006) 1.07
Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics (1992) 0.99
A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene. Anal Biochem (2006) 0.98
Development of genomic reference materials for cystic fibrosis genetic testing. J Mol Diagn (2009) 0.95
Newborn screening for cystic fibrosis. Clin Chest Med (2007) 0.84
A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator. Hum Mutat (1992) 0.83
Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening. Clin Chim Acta (2011) 0.82
Report of two patients with associated conditions in addition to cystic fibrosis. J Cyst Fibros (2010) 0.81
Estimating the age of CFTR mutations predominantly found in Brittany (Western France). J Cyst Fibros (2007) 0.79
Molecular basis of cystic fibrosis in the Republic of Macedonia. Clin Genet (1998) 0.79
Common CFTR gene variants influence body composition and survival in rural Ghana. Hum Genet (2009) 0.77
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem (1997) 4.10
Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem (1996) 3.97
Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr (2001) 3.85
Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab (1998) 3.69
Hyaline membrane disease. Am Rev Respir Dis (1975) 3.20
Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA (1991) 2.94
Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast. Proc Natl Acad Sci U S A (1997) 2.78
Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA (1990) 2.60
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol (2001) 2.59
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia (2008) 2.51
Destabilization of simple repetitive DNA sequences by transcription in yeast. Genetics (1996) 2.39
Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr (1992) 2.36
Mutations in the MSH3 gene preferentially lead to deletions within tracts of simple repetitive DNA in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1995) 2.29
Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol (1998) 2.22
HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data. Public Health Rep (1990) 2.20
Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics (1990) 2.19
Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
Measures of maternal tobacco exposure and infant birth weight at term. Am J Epidemiol (2001) 1.79
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med (2000) 1.78
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr (1991) 1.66
Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics (2001) 1.58
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia (2010) 1.57
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr (1998) 1.57
Half-life of polychlorinated biphenyls in occupationally exposed workers. Arch Environ Health (1990) 1.54
Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem Biol (1998) 1.52
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res (1990) 1.51
Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr (1992) 1.47
Regulation of mitotic homeologous recombination in yeast. Functions of mismatch repair and nucleotide excision repair genes. Genetics (2000) 1.47
Reproductive effects of dibromochlorpropane. Isr J Med Sci (1980) 1.37
Pregnancy outcomes and risk factors in Mexican Americans: the effect of language use and mother's birthplace. Ethn Dis (1997) 1.36
Plasma tocopherol levels and tocopherol-lipid relationships in a normal population of children as compared to healthy adults. Am J Clin Nutr (1978) 1.36
Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics (1998) 1.32
Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis (1975) 1.28
Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Hum Mol Genet (1999) 1.27
The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States. Clin Biochem (2011) 1.26
Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics (1986) 1.26
Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol (1998) 1.26
The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. J Clin Invest (1977) 1.25
Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child (1984) 1.24
The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med (2000) 1.23
Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics (1997) 1.22
Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child (1982) 1.22
Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clin Chem (2000) 1.21
Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet (1993) 1.19
Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem (1999) 1.19
Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics. Pediatrics (1976) 1.18
Genetic analysis of transcription-associated mutation in Saccharomyces cerevisiae. Genetics (2000) 1.17
Preliminary investigation of the use of dried-blood spots for the assessment of in utero exposure to environmental pollutants. Biochem Mol Med (1997) 1.15
Analysis of United States neonatal mortality statistics from 1968 to 1974, with specific reference to changing trends in major causalities. Am J Obstet Gynecol (1977) 1.15
A case report and literature review of "primary" pulmonary histiocytosis X of childhood. Med Pediatr Oncol (1986) 1.14
A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res (1989) 1.14
Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics (1993) 1.14
DNA banking in epidemiologic studies. Epidemiol Rev (1997) 1.12
Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies. Pediatr Pulmonol (2000) 1.12
The incidence of cystic fibrosis. Stat Med (1996) 1.11
Induction of choline phosphotransferase and lecithin synthesis in the fetal lung by corticosteroids. Science (1973) 1.10
Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res (1995) 1.09
Use of DEAE dextran in agar overlays to enhance size of ECHO virus plaques. Public Health Rep (1966) 1.08
Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test. Pediatr Pulmonol (1989) 1.06
Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med (2001) 1.06
Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. J Clin Microbiol (2005) 1.04
Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics (1986) 1.04
Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics (1982) 1.04
Radioimmunoassay for monitoring zidovudine in dried blood spot specimens. Clin Chem (1998) 1.02
Fatty acid abnormalities in cystic fibrosis. Pediatr Res (1985) 1.01
Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics (2000) 1.00
Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr (1999) 1.00
An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem (1987) 0.99
Nephropathy in cadmium workers: assessment of risk from airborne occupational exposure to cadmium. Br J Ind Med (1989) 0.98
Effects of elemental mercury exposure at a thermometer plant. Am J Ind Med (1991) 0.98
Measurement of free choline concentrations in maternal and neonatal blood by micropyrolysis gas chromatography. Clin Chim Acta (1985) 0.96
Effect of lot-to-lot variability in filter paper on the quantification of thyroxin, thyrotropin, and phenylalanine in dried-blood specimens. Clin Chem (1988) 0.96
Newborn screening: principles and practice. Adv Pediatr (1996) 0.95
An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochem Mol Med (1997) 0.95
Terminology and nomenclature for standardization in quantitative fluorescence cytometry. Cytometry (1998) 0.94
Diminished pulmonary lecithin synthesis in acidosis: experimental findings as related to the respiratory distress syndrome. Pediatrics (1976) 0.93
Interlaboratory study of cellular fluorescence intensity measurements with fluorescein-labeled microbead standards. Cytometry (1991) 0.92
Maternal betamethasone and fetal growth and development in the monkey. Am J Obstet Gynecol (1977) 0.92
Utilization of glycogen for phospholipid synthesis in fetal rat lung. Biochim Biophys Acta (1982) 0.92
Lymphatic endothelial cell line (CH3) from a recurrent retroperitoneal lymphangioma. In Vitro Cell Dev Biol (1987) 0.92
The choline incorporation pathway: primary mechanism for de novo lecithin synthesis in fetal primate lung. Pediatr Res (1975) 0.90
Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration. Epidemiology (1999) 0.90
Psychological impact of false-positive results when screening for cystic fibrosis. Pediatr Pulmonol Suppl (1991) 0.90
Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects. Blood (1976) 0.90
State-to-state variations in newborn screening policies. Arch Pediatr Adolesc Med (1997) 0.89
Fetal lung development and the influence of glucocorticoids on pulmonary surfactant. J Steroid Biochem (1977) 0.89
Dopamine beta-hydroxylase. Demonstration of enzymatic ketonization of the product enantiomer S-octopamine. J Biol Chem (1981) 0.89
Cortisol-dihydrotachysterol antagonism in a patient with hypoparathyroidism and adrenal insufficiency: apparent inhibition of bone resorption. J Clin Endocrinol Metab (1976) 0.87
Technical and scientific developments in exposure marker methodology. Clin Chem (1994) 0.86
Performance of succinylacetone assays and their associated proficiency testing outcomes. Clin Biochem (2012) 0.86
Factors influencing HIV-1 banding patterns in miniaturized western blot testing of dried blood spot specimens. J Immunol Methods (1992) 0.86
Pseudomonas serology: confusion, controversy, and challenges. Thorax (2006) 0.86
Detecting the renal effects of cadmium toxicity. Clin Chem (1993) 0.86
Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions. J Biol Chem (1981) 0.86